Back to search
Thrombotic Thrombocytopenic Purpura, Acquired
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Thrombotic Thrombocytopenic Purpura, Acquired trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Thrombotic Thrombocytopenic Purpura, Acquired trials you may qualify forThe general objective of the proposed project is to characterise phenotypically and functionally ADAMTS13-specific memory B lymphocytes and autoreactive T lymph…
Data about efficacy and safety of daratumumab in iTTP refractory or intolerant to standard immunosuppressive treatments are scarce. Therefore, the investigators…
This study aims to investigate whether genetic variation in the TNFAIP3 locus is associated with immune-mediated thrombotic thrombocytopenic purpura (iTTP), and…
This study is a survey in Japan of recombinant ADAMTS13 used to treat or to prevent participants with congenital thrombotic thrombocytopenic purpura (cTTP). The…
Immune thrombotic thrombocytopenic purpura (iTTP) is a rare, life-threatening disorder characterized by microangiopathic hemolytic anemia, severe thrombocytopen…
The objective of this study is to evaluate the efficacy and safety of BCMA/CD19 chimeric antigen receptor (CAR)-modified T cells in the treatment of autoimmune…
The objective of this national, prospective, multi-centre observational study is to describe the prescription rational and practice in Germany, confirm the effi…
This is a study of TAK-755 in adults with immune-mediated thrombotic thrombocytopenic purpura (iTTP). The main aim of this study is to determine the percentage…
Thrombotic thrombocytopenic purpura (or TTP for short) is a condition where blood clots form in small blood vessels throughout the body. The clots can limit or…